Used as a key chiral intermediate in the synthesis of pharmaceuticals, particularly in the production of certain dopamine receptor agonists and antagonists. Its structural features make it valuable in developing drugs for neurological disorders such as Parkinson’s disease and schizophrenia. The compound's enantiomeric purity is critical for ensuring high selectivity and reduced side effects in active pharmaceutical ingredients. It is also employed in research settings for the development of novel bioactive molecules and in asymmetric synthesis due to its rigid, stereodefined scaffold.